CPAP Cancer

Search Interest in Philips CPAP Recall Surges

Published Jul 25, 2026Updated Jul 25, 2026

By People's Justice

What happened

Google Trends data recorded sharp week-over-week increases in searches for terms including "philips cpap recall 2021," "fda philips cpap recall," and "philips cpap recall update," with several related terms reaching "breakout" status. This indicates renewed public attention to the Philips CPAP recall topic, though it does not reflect a new court ruling, settlement, or agency action.

Event date: Jul 24, 2026

Source: trends.google.com

CPAP Cancer case guide Check eligibility

Related news

Oct 3, 2026
CPAP Cancer
Philips Respironics Recalls CPAP and BiPAP Masks After Injury Reports
Philips Respironics recalled certain masks used with its CPAP and BiPAP machines after a medical device report listed 14 serious injuries and no deaths tied to the masks, according to NeurologyLive.
Source: neurologylive.com
Sep 24, 2026
CPAP Cancer
Public Search Interest in CPAP Recall Spikes Sharply
Google Trends data recorded a sharp week-over-week rise in searches for CPAP recall-related terms, led by 'cpap recall 2026' (up 1,800%), 'cpap news' (up 200%), and 'fda cpap recall' (up 180%). Related searches for CPAP side effects, including 'aerophagia' (up 130%) and 'cpap therapy' (up 120%), also rose.
Source: trends.google.com
Jul 20, 2026
CPAP Cancer
Philips announced resolution of the US economic-loss class litigation in MDL 3014 (Sept 7, 2023 press release): predefined cash awards by device type, extended warranties, and a return bonus; Philips' release cites a EUR 575 million Q1 2023 provision and explicitly excludes personal injury and medical monitoring claims.
Philips announced resolution of the US economic-loss class litigation in MDL 3014 (Sept 7, 2023 press release): predefined cash awards by device type, extended warranties, and a return bonus; Philips' release cites a EUR 575 million Q1 2023 provision and explicitly excludes personal injury and medical monitoring claims. The commonly cited $479 million settlement figure is from secondary press coverage (Drugwatch), not Philips' own release — flagged accordingly.
Source: usa.philips.com